Continuous renal replacement therapy versus intermittent hemodialysis in acute renal failure
β Scribed by Cuhaci, Bulent
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 46 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0085-2538
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Although hypotension commonly accompanies intermittent hemodialysis for acute renal failure (arf) in the intensive care unit (icu), little is known about how it may be prevented. online relative blood volume (rbv) monitoring has been used to reduce hypotension in chronic hemodialysis
Uremic toxin removal by renal replacement therapies (RRTs) differs from the elimination of waste products by the native kidney in several ways. Specifically, uremic toxin removal by a RRT is achieved by a one-step membrane-based process, without the subsequent modifications that occur in the native
Oxalic acid is one of the well-known uremic toxins that participates in the pathogenesis of uremic syndrome. Secondary hyperoxalemia is a common feature in patients with chronic renal failure, but oxalate removal is not adequately accomplished by renal replacement therapy. In our series of patients,